Jump to main content
Jump to site search

Issue 7, 2010
Previous Article Next Article

Natural products as antifungal agents against clinically relevant pathogens

Author affiliations

Abstract

Covering: 1990 to 2009

Fungi have emerged worldwide as increasingly frequent causes of healthcare-associated infections, but fungal infections have generally been considered curable, and thus the demand for new antifungal agents has been very low. Although superficial fungal infections of the skin and nails are common and are for the most part treated successfully with existing antifungal agents, serious fungal infections are becoming a growing danger for human health. This is particularly true for AIDS patients, but also for recipients of transplants, and users of antineoplastic agents, corticoids, and even antibiotics. A major problem is the increasing emergence of resistance to antimycotic agents, and since azoles – the most used class of antifungals – suffer a significant incidence of resistance, new efforts are now devoted to the discovery of new agents with different mechanisms of action. Not so long ago, combinatorial chemistry appeared to be the future for drug discovery, but in the late 1990s synthetic chemists realized that combinatorial libraries lacked the “complexity” usually associated with natural compounds. Research into biologically active natural products has thus had a reprise, in particular with the advent of the concept of diversity-oriented synthesis. This review reports what is so far known about natural products as antifungal agents, and provides an overview of natural compounds with both known and unknown mechanisms of action.

Graphical abstract: Natural products as antifungal agents against clinically relevant pathogens

Back to tab navigation

Publication details

The article was received on 21 Dec 2009 and first published on 18 May 2010


Article type: Review Article
DOI: 10.1039/B914961A
Nat. Prod. Rep., 2010,27, 1084-1098

  •   Request permissions

    Natural products as antifungal agents against clinically relevant pathogens

    R. Di Santo, Nat. Prod. Rep., 2010, 27, 1084
    DOI: 10.1039/B914961A

Search articles by author

Spotlight

Advertisements